Revelstoke Capital Partners has invested in Griffin Concierge Medical to enhance personalized primary care services in a growing healthcare market.

Target Information

Griffin Concierge Medical, based in Tampa, Florida, is a full-service primary care group founded in 2008 by Dr. Radley Griffin. The company distinguishes itself by offering a concierge medicine model, which emphasizes individualized and preventive care. This approach fosters strong relationships between patients and providers, enabling longer appointments and same-day access, while also providing 24/7 support. Griffin Concierge Medical focuses on a holistic healthcare experience, prioritizing the long-term health goals of its members.

The team's unique model relies on manageable physician-to-patient ratios that facilitate high-quality care. Patients benefit from innovative services such as preventive screenings, hormone optimization, nutritional counseling, and hospital coordination, all designed to enhance the overall patient experience.

Industry Overview

The healthcare industry in the United States is undergoing a significant transformation, with a growing emphasis on personalized care. Concierge medicine is gaining traction as patients seek alternatives to

View Source

Similar Deals

New Mountain Capital Smarter Technologies

2025

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) United States of America
Unifeye Vision Partners Brooks Eye Associates

2025

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services United States of America
Advantage Capital Gravity Diagnostics

2025

Growth Equity & Expansion Capital Medical & Diagnostic Laboratories United States of America
Eir Partners Porter

2025

Growth Equity & Expansion Capital Home Healthcare Services United States of America
Ampersand Capital Partners Lexington Medical

2025

Growth Equity & Expansion Capital Medical Devices & Implants United States of America
Ampersand Capital Partners Gannet BioChem

2025

Growth Equity & Expansion Capital Biopharmaceuticals United States of America

Revelstoke Capital Partners

invested in

Griffin Concierge Medical

in 2025

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert